- Home
- XPON vs NURO Comparison
XPON vs NURO Comparison
Compare XPON & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- NURO
- Stock Information
- Founded
- XPON 2016
- NURO 1996
- Country
- XPON United States
- NURO United States
- Employees
- XPON N/A
- NURO N/A
- Industry
- XPON Electronic Components
- NURO Medical/Dental Instruments
- Sector
- XPON Technology
- NURO Health Care
- Exchange
- XPON Nasdaq
- NURO Nasdaq
- Market Cap
- XPON 1.8M
- NURO 8.2M
- IPO Year
- XPON 2022
- NURO N/A
- Fundamental
- Price
- XPON $3.27
- NURO $4.42
- Analyst Decision
- XPON
- NURO
- Analyst Count
- XPON 0
- NURO 0
- Target Price
- XPON N/A
- NURO N/A
- AVG Volume (30 Days)
- XPON 3.1M
- NURO 14.4K
- Earning Date
- XPON 11-07-2024
- NURO 11-01-2024
- Dividend Yield
- XPON N/A
- NURO N/A
- EPS Growth
- XPON N/A
- NURO N/A
- EPS
- XPON N/A
- NURO N/A
- Revenue
- XPON $4,998,801.00
- NURO $4,383,614.00
- Revenue This Year
- XPON $0.68
- NURO N/A
- Revenue Next Year
- XPON $29.04
- NURO N/A
- P/E Ratio
- XPON N/A
- NURO N/A
- Revenue Growth
- XPON N/A
- NURO N/A
- 52 Week Low
- XPON $2.09
- NURO $2.66
- 52 Week High
- XPON $639.00
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- XPON 37.66
- NURO 65.06
- Support Level
- XPON $2.70
- NURO $3.96
- Resistance Level
- XPON $4.29
- NURO $4.69
- Average True Range (ATR)
- XPON 0.77
- NURO 0.22
- MACD
- XPON 0.50
- NURO 0.04
- Stochastic Oscillator
- XPON 33.62
- NURO 82.35
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.